Literature DB >> 6143138

Long-term study of management of rheumatoid arthritis.

R Million, J H Kellgren, P Poole, M I Jayson.   

Abstract

A 10-year study of the management of rheumatoid arthritis was conducted to compare a programme consisting of rest and anti-inflammatory and antirheumatic drugs with one consisting of maintenance of activity, anti-inflammatory and antirheumatic drugs, and systemic steroids where necessary. During this period subjects who did not respond to the treatment allocated went on to a combined treatment programme of rest, anti-inflammatory and antirheumatic drugs, and steroids. Among those who remained in the trial for the 10 years, there was little difference between the two groups in morning stiffness, number of inflamed joints, functional capacity, grip strength, number of American Rheumatism Association criteria present, and whether they remained on their original treatment programme or switched to the combined programme. However, in those who started in the steroid group, the condition of several joints tended to be better clinically and radiologically than in those of the other group during and at the end of 10 years of the original treatment programme, at time of transfer to the combined programme, and at the completion of the combined programme. Both groups had as many complications of disease and treatment, and adverse effects attributable to steroids seemed to be restricted to those with severe disease who had not responded to their original programme. A policy of maintaining physical activity plus the judicious use of steroids where required produces, in the long term, results as good as or probably better than a regimen of bed rest and no steroids.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6143138     DOI: 10.1016/s0140-6736(84)92270-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  9 in total

Review 1.  Low dose corticosteroids in early rheumatoid arthritis. Can these drugs slow disease progression?

Authors:  J R Kirwan; K K Lim
Journal:  Drugs Aging       Date:  1996-03       Impact factor: 3.923

2.  Corticosteroids in rheumatoid arthritis: is a trial of their 'disease modifying' potential feasible?

Authors:  M A Byron; J R Kirwan
Journal:  Ann Rheum Dis       Date:  1986-02       Impact factor: 19.103

Review 3.  Immunosuppressive drugs and corticosteroids in the treatment of rheumatoid arthritis.

Authors:  M Arnold; L Schrieber; P Brooks
Journal:  Drugs       Date:  1988-09       Impact factor: 9.546

4.  Meta-analysis of short-term low dose prednisolone versus placebo and non-steroidal anti-inflammatory drugs in rheumatoid arthritis.

Authors:  P C Gøtzsche; H K Johansen
Journal:  BMJ       Date:  1998-03-14

Review 5.  Glucocorticoid use in rheumatoid arthritis.

Authors:  Kenneth G Saag
Journal:  Curr Rheumatol Rep       Date:  2002-06       Impact factor: 4.592

6.  Muscle strength, endurance, and aerobic capacity in rheumatoid arthritis: a comparative study with healthy subjects.

Authors:  C Ekdahl; G Broman
Journal:  Ann Rheum Dis       Date:  1992-01       Impact factor: 19.103

7.  Osteoporosis in rheumatoid arthritis: safety of low dose corticosteroids.

Authors:  P N Sambrook; J A Eisman; M G Yeates; N A Pocock; S Eberl; G D Champion
Journal:  Ann Rheum Dis       Date:  1986-11       Impact factor: 19.103

8.  A randomised placebo controlled 12 week trial of budesonide and prednisolone in rheumatoid arthritis.

Authors:  J R Kirwan; R Hällgren; H Mielants; F Wollheim; E Bjorck; T Persson; C Book; S Bowman; M Byron; N Cox; M Field; L Kanerud; M Leirisalo-Repo; M Malaise; A Mohammad; R Palmer; I F Petersson; B Ringertz; P Sheldon; M Simonsson; N Snowden; F Van den Bosch
Journal:  Ann Rheum Dis       Date:  2004-06       Impact factor: 19.103

Review 9.  Short-term low-dose corticosteroids vs placebo and nonsteroidal antiinflammatory drugs in rheumatoid arthritis.

Authors:  P C Gotzsche; H K Johansen
Journal:  Cochrane Database Syst Rev       Date:  2004
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.